← Back to Search

MTM + CHW Support for Type 2 Diabetes (ENRxICH Trial)

N/A

Recruiting

Led By Olayinka Shiyanbola, PhD, BPharm

Research Sponsored by University of Wisconsin, Madison

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months and 12 months

Awards & highlights

ENRxICH Trial Summary

This trial aims to improve diabetes self-management in Black & Hispanic adults with type 2 diabetes, by exploring the best way to use medicines & support from pharmacists & Community Health Workers.

Who is the study for?

This trial is for Black and Hispanic adults aged 18-90 with type 2 diabetes, who speak English or Spanish. They must live in the study area, have a phone, take diabetes medication from the study pharmacy, and have an HbA1c of at least 8%. They can't join if they've had similar medicine management support recently or are in another program.Check my eligibility

What is being tested?

The study tests four approaches to improve diabetes self-management: usual care; added pharmacist support for medicine management; help from a Community Health Worker (CHW) with life challenges; or both pharmacist and CHW support. Participants will be randomly placed into one of these groups.See study design

What are the potential side effects?

Since this trial focuses on management approaches rather than new medications, side effects may not be directly related to treatments but could include stress or discomfort due to changes in routine healthcare practices.

ENRxICH Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months and 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months and 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in mean hemoglobin A1c score

Secondary outcome measures

Change in medication adherence - medication refill

Mean scores on the Adherence to Refills and Medications Scale for Diabetes

ENRxICH Trial Design

4Treatment groups

Experimental Treatment

Active Control

Group I: Medication Therapy Management (MTM)Experimental Treatment1 Intervention

Group II: MTM + CHWExperimental Treatment2 Interventions

Group III: Community Health Worker (CHW)Experimental Treatment1 Intervention

Group IV: Usual CareActive Control1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

CHW

2020

N/A

~200

MTM

2015

N/A

~1420

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,359 Previous Clinical Trials

4,314,216 Total Patients Enrolled

106 Trials studying Diabetes

138,287 Patients Enrolled for Diabetes

University of Wisconsin, MadisonLead Sponsor

1,189 Previous Clinical Trials

3,169,170 Total Patients Enrolled

6 Trials studying Diabetes

169 Patients Enrolled for Diabetes

Olayinka Shiyanbola, PhD, BPharmPrincipal InvestigatorUniversity of Wisconsin, Madison

2 Previous Clinical Trials

61 Total Patients Enrolled

1 Trials studying Diabetes

30 Patients Enrolled for Diabetes

Media Library

Medication Therapy Management (MTM) Clinical Trial Eligibility Overview. Trial Name: NCT05912647 — N/A

Diabetes Research Study Groups: Usual Care, Medication Therapy Management (MTM), Community Health Worker (CHW), MTM + CHW

Diabetes Clinical Trial 2023: Medication Therapy Management (MTM) Highlights & Side Effects. Trial Name: NCT05912647 — N/A

Medication Therapy Management (MTM) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05912647 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research encompass elderly individuals aged 70 or above?

"The parameters for this medical study require that the participants are between 18 and 90 years old. There exist 205 trials available to those below 18, while 1163 trails cater specifically to elderly individuals above 65."

Answered by AI

Are there any eligibility criteria to participate in this research?

"In order to be eligible for this medical trial, participants must have type 2 diabetes and fall within the age range of 18-90. A total of 376 individuals are being recruited in a bid to assess efficacy."

Answered by AI

Are there currently any openings for volunteers to join this experiment?

"Clinicialtrials.gov reports that this medical trial, which first appeared on July 1st 2023 and was last edited on June 12th 2023, is no longer looking for participants. Fortunately, there are still 1495 active studies accepting applicants at the moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Enhancing Diabetes Management Approaches for Black and Hispanic Patients With Uncontrolled Diabetes

2024. "Enhancing Diabetes Management Approaches for Black and Hispanic Patients With Uncontrolled Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05912647.